Colin Thorpe

Title: Colin Thorpe: Innovator in Bioorthogonal Reactivity

Introduction

Colin Thorpe is a distinguished inventor based in Newark, DE (US). He has made significant contributions to the field of bioorthogonal chemistry, holding a total of 4 patents. His innovative methods have the potential to advance various applications in chemical biology.

Latest Patents

Colin Thorpe's latest patents focus on methods for inducing bioorthogonal reactivity. One of his notable inventions is a method for catalytically converting a dihydrotetrazine into a tetrazine. This method involves providing the dihydrotetrazine in a reaction medium and adding an enzyme as a catalyst along with an oxidant. Another patent describes a similar method where one R group on the dihydrotetrazine is a substituted or unsubstituted aryl, and the other R group is selected from various chemical groups. This method also emphasizes the importance of oxidizing dihydrotetrazine in the presence of a catalyst and a stoichiometric oxidant.

Career Highlights

Colin Thorpe is affiliated with the University of Delaware, where he continues to engage in groundbreaking research. His work has garnered attention for its innovative approach to chemical reactions and its implications for future scientific advancements.

Collaborations

Colin collaborates with esteemed colleagues such as Joseph M. Fox and Yixin Xie. Their combined expertise enhances the research output and fosters a collaborative environment for innovation.

Conclusion

Colin Thorpe's contributions to bioorthogonal chemistry exemplify the spirit of innovation in scientific research. His patents not only reflect his expertise but also pave the way for future advancements in the field.